Back to results
US 2026/0035346 A1Published application
Co-crystals of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone and methods
AssigneeEpicentRx, Inc.
InventorsJames KANTER, Bryan T. ORONSKY, Scott CAROEN, Tony R. REID
Life of this patent
Estimating the term…
Abstract
The present disclosure relates generally to crystals, and more specifically to co-crystals of RRx-001 or 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone and methods of preparing and using the co-crystals to treat or prevent various diseases, disorders, and conditions.
Claims33
A co-crystal comprising:
- Compound I
- and
- calcium chloride, pyridoxine HCl, thiamine HCl, ferric chloride, manganese chloride, or zinc chloride.
-19. (canceled)
-37. (canceled)
-55. (canceled)
-65. (canceled)
67-75. (canceled)
-84. (canceled)
-91. (canceled)
(canceled)
-99. (canceled)
-107. (canceled)
-117. (canceled)
-127. (canceled)
-136. (canceled)
Dependencies are inferred from the claim text.